What Tecres does

Tecres S.p.A. is an Italian medical device manufacturer founded in 1981 and headquartered in Sommacampagna (Verona), operating as a wholly-owned subsidiary of Demetra Holding S.p.A. The company develops acrylic resin-based biomaterials and devices across four clinical areas: orthopedic bone cements, preformed antibiotic-loaded spacers for prosthetic joint infection (PJI) revision, vertebral augmentation resins and delivery systems, and cranioplasty solutions. Its core product families include Cemex® bone cements (launched 1986 with a proprietary powder formulation requiring less monomer than conventional cements), Spacer® preformed spacers (launched 1996, the first preformed spacer on the market, with documented infection eradication rates exceeding 91%), Vancogenx® dual-antibiotic cements, Cal-Cemex® hybrid bone substitute combining beta-tricalcium phosphate with PMMA, and the Mendec® vertebral augmentation line (including the Mendec® Aqua hydraulic delivery system with 155cm tubing and 3x force multiplication).

Tecres serves orthopedic surgeons, interventional radiologists, neurosurgeons, and trauma surgeons in hospitals and surgical centers across more than 100 countries via a distributor network that covers every continent, supplemented by direct engagement through the Tecres Academy education platform and sales partnership programs. Commercial model is hardware sales of medical devices on a quote-based pricing structure that is not publicly disclosed; revenue mechanics reflect negotiated enterprise contracts with regional distributors rather than transactional SMB sales. The company supports its claims with 250+ peer-reviewed publications on the Spacer® line, 1,200+ documented clinical cases, and reports helping more than 2 million patients annually. Certifications include ISO 13485:2016, ISO 9001:2015, EU MDR (granted 2023 for the core range and Vancogenx-Space® Knee), and an EcoVadis Bronze Medal (2023).

Under Demetra Holding's coordination, the group includes Osartis, OsteoRemedies, Yijiutai, and recently acquired GetSet™ Surgical (February 2025), Next Science, LTD (September 2025), and Maxxspine Innovative GmbH (May 2026), reflecting an active inorganic expansion strategy around orthopedic infection management and integrated surgical workflows. Tecres leadership underwent a generational transition in March 2024, with Michele Perrino becoming CEO, Denis Faccioli taking the President role, and founder Giovanni Faccioli assuming Honorary President. Headcount is reported at 51–100 employees, with a stated share capital of €850,000.

Name

Tecres

Legal name

Tecres S.p.A.

Website

https://tecres.com

Company type

Private

Founded year

1981

Operating status

Operating

Headcount range

51–100 employees

Short description

Tecres is an Italian medical device manufacturer, founded in 1981, that develops acrylic resin bone cements, antibiotic-loaded preformed spacers, and vertebral augmentation systems for orthopedic surgeons, neurosurgeons, and interventional radiologists across more than 100 countries.

Ownership category

akta.pro rank

Product category

Orthopedic and Neurosurgical Medical Devices (Acrylic Resin Bone Cements, Spacers, Vertebral Augmentation, and Cranioplasty Implants)

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)

akta.pro secondary industries

Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB), Neurosurgical Implants & Cranial/CMF (Cranial Plates, Dural Repair, Shunts) (HLAHAEAD), 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ)

Keywords

• Orthopedic bone cement
• Preformed joint spacers
• Vertebral augmentation systems
• Cranioplasty implants
• Acrylic medical resins

Headquarters

HQ city

Sommacampagna

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Medical Device Product Sales: Direct sales of bone cement products, preformed spacers, vertebral augmentation materials, bone void fillers, and accessories to hospitals and healthcare providers through distributor network.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Core offering

Tecres S.p.A. is an Italian medical device manufacturer specializing in acrylic resin-based products for orthopedic, spine, trauma, and neurosurgical applications. Its portfolio spans PMMA bone cements (Cemex®, Cemfix®, Cal-Cemex®), preformed antibiotic-loaded temporary joint spacers (Spacer-S, Spacer-K, Spacer-G, Spacer-V, Vancogenx-Space®), vertebral augmentation systems (Mendec® Spine, X-Truder®, Shakit®, Mendec® Aqua), and patient-specific cranioplasty implants (Cranos®, Mendec® Cranio, Endorthesis). These products are used by orthopedic surgeons, neurosurgeons, interventional radiologists, and maxillofacial surgeons in hospitals and surgical centers for fracture fixation, prosthesis fixation, infection management, vertebral compression fracture treatment, and cranial reconstruction.

Product overview

Tecres is a medical device company specializing in acrylic resins for orthopedics, vertebral augmentation, and cranioplasty since 1986. The product portfolio is organized around several core lines: (1) Cemex® bone cement line - antibiotics-loaded and standard cements in various viscosities for joint implant fixation; (2) Spacer®/Vancogenx-Space® preformed spacers for hip, knee, and shoulder PJI revision with antibiotic loading options; (3) Mendec® vertebral augmentation line including spine resins (low/medium/high viscosity), delivery systems (Mendec® Aqua hydraulic system), and all-in-one kits; (4) Cal-Cemex® hybrid bone substitute combining beta-tricalcium phosphate and PMMA; (5) Cranioplasty solutions including Cranos® patient-specific implants and Mendec® Cranio; (6) Accessories including X-Truder®, Shakit®, needles, and cementation tools; (7) Distributed products like Tripod-Fix® vertebral augmentation system and BioBall® modular prosthesis head. The company operates under Demetra Holding and holds ISO 13485, ISO 9001, and EU MDR certifications.

Differentiator

Problem solved

Functional benefit

Products and services

• Cemex® Bone Cement Line PMMA acrylic resin bone cements (regular and antibiotic-loaded variants such as Cemex® Genta and Cemex® 3) used by orthopedic surgeons for prosthesis fixation in primary and revision arthroplasty and in trauma surgery.
• Spacer® Preformed Temporary Joint Spacers (Spacer-S, Spacer-K, Spacer-G, Spacer-V) Factory-molded PMMA spacers preloaded with antibiotics, used by orthopedic surgeons to maintain joint space and deliver local antibiotic therapy between stages of revision for infected arthroplasties (periprosthetic joint infection).
• Vancogenx-Space® Preformed temporary hip spacer loaded with two antibiotics (gentamicin and vancomycin) used by orthopedic surgeons in two-stage treatment of infected total hip arthroplasty caused by resistant organisms.
• Cal-Cemex® Hybrid Bone Substitute Hybrid calcium sulfate / PMMA bone substitute used by orthopedic and trauma surgeons as bone-void filler; combines resorbable and acrylic components to support bone defect management in arthroplasty and trauma.
• Cemfix® Bone Cement PMMA acrylic bone cement for orthopedic prosthesis fixation, sold alongside the Cemex® family as part of Tecres' bone cement portfolio.
• Endorthesis Screw Acrylic resin orthopedic screw used by orthopedic surgeons in trauma and arthroplasty procedures.
• Mendec® Spine System (Vertebroplasty / Kyphoplasty) Acrylic bone cement and delivery system for percutaneous vertebral augmentation, used by spine surgeons and interventional radiologists for treatment of painful vertebral compression fractures.
• X-Truder® Cement Delivery System Mechanical cement delivery gun used in conjunction with Mendec® Spine cement for controlled percutaneous injection during vertebral augmentation procedures.
• Shakit® and Mendec® Aqua (Spine Kit Systems) Spine augmentation kit systems used together with Mendec® Spine cement and the X-Truder® delivery gun in percutaneous vertebral augmentation procedures.
• Cranos® Patient Specific Implants Custom-designed PMMA cranial implants (Cranos® 3D, Cranos® Cranial) used by neurosurgeons and maxillofacial surgeons for reconstruction of cranial defects following trauma, tumor resection, or decompressive craniectomy; each implant is designed from patient CT imaging.
• Mendec® Cranio Cranioplasty Cement PMMA acrylic bone cement formulated for cranial reconstruction, used by neurosurgeons as an intraoperative shaping material for cranial defect repair where a patient-specific implant is not used.
• BioBall® Adapter System™ (Distributed) Adapter system for orthopedic hip revision solutions, distributed by Tecres alongside its own bone-cement and spacer portfolio to extend its offering in arthroplasty revision.
• Tripod-Fix® (Distributed) External fixator device distributed by Tecres, complementing its internal-fixation and bone-cement offering for orthopedic trauma procedures.

Quantifiable outcome

• Infection eradication rate exceeding 91% at mean follow-up of 56 months
• +4 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Five partnerships are on record, tiered core.

• Maxxspine Innovative GmbHcoreStrategic or Co-development Partner · 18 May 2026German company acquired by Demetra marking strategic step in building integrated surgical workflows for orthopedic and spine surgeons worldwide.
• Next Science, LTDcoreStrategic or Co-development Partner · 16 September 2025Leading provider of microbial-burden solutions. Demetra acquired majority assets of Next Science, reinforcing leadership as company of choice for infection management.
• RIR Tech4LifecoreStrategic or Co-development Partner · 18 June 2025Research consortium (Rete Interregionale di Ricerca) through which Tecres participates in INTELLI-MI project. Collaboration involves 9 Veneto companies and Universities of Padova, Verona and Ca' Foscari di Venezia for intelligent technologies in medical innovation.
• GetSet™ SurgicalcoreStrategic or Co-development Partner · 27 February 2025Swiss company specializing in medical sector. Acquired by Demetra Group (parent company of Tecres) through majority shareholding. Part of the outstanding medical sector group headed by Demetra.
• Wiltrom Co., Ltd.coreChannel Partner/ Reseller/ Distributor · 1 July 2024Taiwan-based medical device company specializing in design and development. Tecres partnered with Wiltrom for distribution of Tripod-Fix® Vertebral Body Augmentation System in Spain, Poland, Switzerland, Greece, Austria, and Slovenia. Tripod-Fix® is indicated for reduction of vertebral fractures due to osteoporotic compression and has been used in more than 1,400 real world clinical cases.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Stryker: Stryker is a major orthopedic and spine incumbent that competes directly through its bone cement, kyphoplasty/vertebroplasty, and cranioplasty portfolios; its scale and bundling make it a constant share threat to Tecres across multiple product categories.
• Smith+Nephew: Smith+Nephew competes in orthopedics and trauma with relevant bone cement and joint reconstruction offerings, and is a frequent comparable for European mid-market ortho-medtech players like Tecres.
• Medtronic: Medtronic is a leader in vertebral augmentation (kyphoplasty/vertebroplasty) and spine, directly overlapping with Tecres' Mendec® line and broader spine strategy within Demetra.
• Zimmer Biomet: Zimmer Biomet is a top-tier joint reconstruction incumbent that supplies bone cements alongside its hip and knee implants, competing with Tecres on the cement side of joint reconstruction and revision procedures.
• DePuy Synthes (Johnson & Johnson): DePuy Synthes competes with Tecres across orthopedic cements, trauma fixation, and spine/vertebral augmentation as part of its broad musculoskeletal portfolio and global commercial reach.

Direct peers

• KLS Martin Group: KLS Martin is a direct competitor in cranioplasty and CMF solutions (including patient-specific implants), with comparable expertise in cranial reconstruction that overlaps with Tecres' Cranos® line.
• Heraeus Medical: Heraeus Medical is the global leader in PMMA bone cements and the most direct competitor to Tecres' Cemex® line, with comparable antibiotic-loaded offerings and broad geographic reach in orthopedics.
• Globus Medical: Globus Medical is a spine-focused peer with a meaningful vertebral augmentation franchise, competing with Tecres' Mendec® line as the market consolidates around integrated spine workflow providers.
• Integra LifeSciences: Integra LifeSciences competes with Tecres in neurosurgery and cranial reconstruction (including patient-specific implants and dural repair), and shares a similar European-anchored specialty medtech profile.

Emerging players

• OssDsign: OssDsign is an emerging player in patient-specific cranial implants and regenerative orthobiologics, addressing a similar premium, customization-driven cranioplasty niche as Tecres' Cranos® products.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/tecres
• YouTubeyoutube.com/@TecresSpA

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tecres